Summary
The ERC proof-of-concept project CONQUEST (COmpanion Nanodiagnostics for QUantifying Epr and Stratifying patients to Targeted nanotherapies) aimed to explore the possibilities of commercializing a first-of-its-kind platform technology for visualizing and quantifying the...